Kowa Company Ltd.
WOKINGHAM, England, July 22, 2010 - Kowa are delighted to announce that following the completion of
the decentralized regulatory procedure, that their statin, pitavastatin
has achieved a positive outcome from the UK Regulatory Authority
(MHRA) acting as the Reference Member State for 16 EU countries.
